Recently, the Wnt5a/ROR1 signaling was shown to induce NFκB-target gene expression in CLL cells, thus increasing IL-6 level, which, in turn, induces STAT3 activation [118]. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.